Olglimide-M 1 Tablet PR
Marketer
Olcare Laboratories
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Olglimide-M 1 Tablet PR
Diabex Duo, a single-dose tablet, is an antidiabetic medication combining two active ingredients for managing type 2 diabetes in adults. It effectively regulates blood glucose levels. Diabex Duo should be administered with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can lead to elevated glucose levels and increased risk of complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Diabex Duo is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremor. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. Diabex Duo is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before starting treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended.
Primary Ingredients of Olglimide-M 1 Tablet PR
No information provided. Please provide the text you wish me to rephrase.
Uses of Olglimide-M 1 Tablet PR
Managing type 2 diabetes
Major Benefits of Olglimide-M 1 Tablet PR:
Follow your doctor's instructions or consult the product label for dosage information. Administer one Olglimide-M tablet post-prandially.
Common Side effects of Olglimide-M 1 Tablet PR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Olglimide-M 1 Tablet PR:
Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer one Olglimide-M tablet post-prandially.
How Olglimide-M 1 Tablet PR works:
Olglimide-M PR, a single-tablet formulation, unites glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts through a three-pronged mechanism: diminishing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Olglimide-M 1 Tablet PR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Olglimide-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingUNSAFE
Maternal use of Olglimide-M 1 Tablet PR is contraindicated while breastfeeding due to the potential for infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with impaired kidney function should use Olglimide-M 1 Tablet PR with careful consideration; dosage modification might be necessary. Consult your physician for guidance. Olglimide-M 1 Tablet PR is contraindicated in individuals with severely compromised renal function. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Olglimide-M 1 Tablet PR cautiously, potentially requiring dose modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, Olglimide-M 1 Tablet PR initiation typically begins with a reduced dosage; however, it's contraindicated in those with severe hepatic dysfunction.
What if you forget to take Olglimide-M 1 Tablet PR :
Should you forget to take your Olglimide-M 1 Tablet PR, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Olglimide-M 1 Tablet PR
Label | Value |
---|---|
Developing Habits | No. |
Type of Therapy | Diabetes Treatment |